Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts.

Date publication

juin 2024

Journal

ESMO open

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DEBIEUVRE Didier

Tous les auteurs :
Hoang TCT, Debieuvre D, Bravard AS, Martinez S, Le Garff G, Jeandeau S, Petit L, Marquette D, Amrane K, Demontrond P, Tiercin M, Jarjour B, Turlotte A, Masson P, Jaafar M, Hauss PA, Morel H,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38848661

Résumé

The impact of the most recent advances, including targeted therapies and immune checkpoint inhibitors, on early (3-month) mortality in lung cancer is unknown. The aims of this study were to evaluate the real-world rate of and risk factors for early mortality, as well as trends in early mortality over the last 20 years.

Mots clés

early mortality, lung cancer, mortality rate, non-small-cell lung cancer, risk factor

Référence

ESMO Open. 2024 06 6;9(6):103594